0000899243-20-001092.txt : 20200113
0000899243-20-001092.hdr.sgml : 20200113
20200113171724
ACCESSION NUMBER: 0000899243-20-001092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200109
FILED AS OF DATE: 20200113
DATE AS OF CHANGE: 20200113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Batycky Richard P.
CENTRAL INDEX KEY: 0001646596
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36199
FILM NUMBER: 20524359
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulmatrix, Inc.
CENTRAL INDEX KEY: 0001574235
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461821392
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 390
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: (781) 357-2333
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 390
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: Ruthigen, Inc.
DATE OF NAME CHANGE: 20130411
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-09
0
0001574235
Pulmatrix, Inc.
PULM
0001646596
Batycky Richard P.
C/O PULMATRIX, INC.,
99 HAYDEN AVE, SUITE 390
LEXINGTON
MA
02421
1
0
0
0
Stock Option (Right to Buy)
1.54
2020-01-09
4
A
0
30000
0.00
A
2030-01-09
Common Stock
30000
30000
D
Twenty-five percent (25%) of this option will vest and become exercisable on November 1, 2020 (the "First Vesting Date"), and the remaining shares underlying the option will vest and become exercisable in thirty-six (36) equal monthly installments on each monthly anniversary of the First Vesting Date thereafter, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.
/s/ Richard Batycky
2020-01-13